A study to evaluate the treatment patterns and characteristics of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus.
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2015
At a glance
- Drugs Everolimus (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 06 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.